Corporate Banner
Satellite Banner
RNAi
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Researchers Reactivate Gene to Rejuvenate Tissue Repair, Identify Gene that Promotes Stem Cell Self-Renewal

Published: Tuesday, November 12, 2013
Last Updated: Tuesday, November 12, 2013
Bookmark and Share
Two groups of scientists have made complementary discoveries that break new ground on efforts to turn back the body’s clock on cellular activity.

A team led by Dr. Sean Morrison, Director of CRI and Professor of Pediatrics at UT Southwestern Medical Center, has identified an RNA-binding protein called IMP1 that promotes stem cell self-renewal during fetal development. Self-renewal is the process by which stem cells divide to make more stem cells, which is important for the growth of tissues during fetal development and the regeneration of tissues throughout adult life.

At the same time, researchers including Dr. Hao Zhu, who also directs a lab at CRI and is Assistant Professor of Pediatrics and Internal Medicine at UT Southwestern, have shown that another RNA-binding protein, Lin28a, also promotes tissue repair by reactivating a metabolic state reminiscent of the juvenile developmental stage.

Dr. Zhu’s research, published in Cell, showed that reactivation of Lin28a – a gene that is normally turned on in fetal but not adult tissues – substantially improved hair regrowth and accelerated tissue repair after ear and digit injuries.

“Our work found that Lin28a promotes regeneration through a metabolic mechanism,” said Dr. Zhu. “This finding opens up an exciting possibility that metabolism could be modulated to improve tissue repair, whereby metabolic drugs could be employed to promote regeneration.”

Dr. Morrison’s investigation, published in the online journal eLife, identified a set of genes including IMP1 that are turned on only within time-limited windows, and control developmental switches in stem cell properties between fetal development and adulthood.
IMP1 is turned off during late fetal development, partly as a consequence of increasing expression of a third family of RNA-binding molecules called let-7 microRNAs. Importantly, let-7 microRNAs are turned on during late fetal development in part due to declining expression of Lin28a.

Drs. Morrison and Zhu’s laboratories both studied molecules at different ends of the same pathway – one that regulates stem cell self-renewal and tissue regeneration by modulating the expression of a network of RNA-binding proteins.

“These results are interesting because let-7-regulated networks were first discovered based on their ability to regulate the timing of developmental transitions in worms,” said Dr. Morrison. “This earlier finding suggests that the mechanisms employed by mammalian tissue stem cells to regulate changes in their properties over time are at least partly conserved and depend upon mechanisms inherited from invertebrates.”

A previous study from the Morrison laboratory found that expression of let-7 increases throughout adulthood, reducing the activity of stem cells in older animals. The current findings show that IMP1 inhibits the expression of genes that trigger stem cells to commit to specific fates, while promoting the expression of genes related to self-renewal. Further studies are likely to identify many more genetic targets that enable stem cells to adapt their properties to the changing growth and regeneration demands of tissues over an organism’s life span.

Together, these studies demonstrate that a network of RNA-binding proteins that are turned on specifically during fetal development promote stem cell function and tissue growth by regulating cellular proliferation and metabolism. The loss of Lin28a and IMP1 expression from adult tissues partly explains why adult tissues no longer grow and have less stem cell function than fetal tissues. Thus, by modulating the function of these pathways in adult stem cells, it may be possible to enhance tissue regeneration.

Dr. Zhu’s work was initiated while he was a postdoctoral fellow in Dr. George Daley’s laboratory at Boston Children’s Hospital. Other members of the Daley laboratory, including Shyh-Chang Ng, contributed to this study, and Dr. Daley was senior author on the paper. The work in the Zhu and Morrison laboratories was supported by the National Institutes of Health and the Cancer Prevention and Research Institute of Texas.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More than 4,900+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Researchers Develop Software That Could Facilitate Drug Development
AptaTRACE can identify aptamers, potentially speed drug advancement.
Gene Therapy for Metabolic Liver Diseases
Researchers have tested gene therapy in pigs from hereditary tyrosinemia type 1, with corrected liver cells being transplanted into the diseased liver.
Gene Terapy for Muscle Wasting Developed
New gene therapy could save millions of people suffering from muscle wasting disease.
Testing Nanoparticle Drug Delivery in Dogs
Scientists have tested a nanoparticle drug delivery against bone cancer in dogs with promising results.
Fighting Cancer Through Protein Pathways
Researchers have found a new drug target within a protein production pathway critical to regulating growth and proliferation of cells.
Triple-Action Therapy Patch Shows Promise
Patch that delivers drug, gene, and light-based therapy to tumor sites shows promising results in mice.
Cancer Gene-Drug Combinations Ripe for Precision Medicine
The study aims to expand the number of cancer gene mutations that can be paired with a precision therapy.
Exploiting Malaria’s Achilles’ Heel
Researchers have uncovered an Achilles' heel in malaria's anti-drug treatment arsenal that could lead to a disease cure.
Targeting BRAF Mutations in Thyroid Cancer
Treating metastatic thyroid cancer patients harboring a BRAF mutation with vemurafenib showed anti-tumor activity in a third of patients.
Colon Cancer Blocked in Mice
Case Western Reserve University Researchers block common type of colon cancer tumour in mice, laying groundwork for human clinical trial.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!